Heart Historical Income Statement

HSCS Stock  USD 3.83  0.41  11.99%   
Historical analysis of Heart Test income statement accounts such as Selling General Administrative of 2.5 M or Total Revenue of 20.5 K can show how well Heart Test Laboratories performed in making a profits. Evaluating Heart Test income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Heart Test's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Heart Test Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Heart Test Laboratories is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

About Heart Income Statement Analysis

Heart Test Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Heart Test shareholders. The income statement also shows Heart investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Heart Test Income Statement Chart

At this time, Heart Test's Total Revenue is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 11.8 K in 2024, despite the fact that Net Interest Income is likely to grow to (336.4 K).

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Heart Test Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Heart Test Laboratories. It is also known as Heart Test overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Heart Test Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Heart Test Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Heart Test income statement and is an important metric when analyzing Heart Test Laboratories profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.
Most accounts from Heart Test's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Heart Test Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
At this time, Heart Test's Total Revenue is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 11.8 K in 2024, despite the fact that Net Interest Income is likely to grow to (336.4 K).
 2021 2022 2023 2024 (projected)
Interest Expense371.6K243.2K354.1K242.9K
Depreciation And Amortization26.6K26.9K95.1K58.5K

Heart Test income statement Correlations

0.59-0.99-0.560.930.85-0.720.780.780.73-0.890.730.93-0.730.30.780.830.28-0.27
0.59-0.6-0.070.770.79-0.160.20.20.15-0.320.160.74-0.170.940.20.230.53-0.53
-0.99-0.60.56-0.94-0.850.72-0.73-0.73-0.680.88-0.69-0.940.73-0.31-0.73-0.79-0.310.3
-0.56-0.070.56-0.55-0.630.96-0.89-0.89-0.90.64-0.91-0.510.960.14-0.89-0.88-0.660.65
0.930.77-0.94-0.550.92-0.650.680.680.63-0.710.640.99-0.660.50.680.730.51-0.51
0.850.79-0.85-0.630.92-0.720.740.740.7-0.740.720.88-0.730.610.740.760.69-0.69
-0.72-0.160.720.96-0.65-0.72-0.95-0.95-0.950.83-0.95-0.611.00.08-0.95-0.96-0.540.53
0.780.2-0.73-0.890.680.74-0.951.01.0-0.831.00.64-0.95-0.041.00.990.45-0.44
0.780.2-0.73-0.890.680.74-0.951.01.0-0.831.00.65-0.95-0.041.00.990.44-0.44
0.730.15-0.68-0.90.630.7-0.951.01.0-0.81.00.59-0.95-0.081.00.990.45-0.45
-0.89-0.320.880.64-0.71-0.740.83-0.83-0.83-0.8-0.81-0.690.84-0.08-0.83-0.87-0.20.19
0.730.16-0.69-0.910.640.72-0.951.01.01.0-0.810.6-0.95-0.061.00.990.47-0.46
0.930.74-0.94-0.510.990.88-0.610.640.650.59-0.690.6-0.630.460.650.70.45-0.45
-0.73-0.170.730.96-0.66-0.731.0-0.95-0.95-0.950.84-0.95-0.630.07-0.95-0.96-0.540.54
0.30.94-0.310.140.50.610.08-0.04-0.04-0.08-0.08-0.060.460.07-0.04-0.030.49-0.5
0.780.2-0.73-0.890.680.74-0.951.01.01.0-0.831.00.65-0.95-0.040.990.44-0.44
0.830.23-0.79-0.880.730.76-0.960.990.990.99-0.870.990.7-0.96-0.030.990.43-0.42
0.280.53-0.31-0.660.510.69-0.540.450.440.45-0.20.470.45-0.540.490.440.43-1.0
-0.27-0.530.30.65-0.51-0.690.53-0.44-0.44-0.450.19-0.46-0.450.54-0.5-0.44-0.42-1.0
Click cells to compare fundamentals

Heart Test Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.